We are monitoring the impact of COVID-19 on Virology Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4929
Share on
Share on

Global Virology Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Application, End User and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4929
Pages: 185

Virology Market Size (2021 to 2026)

The global virology market size is expected to showcase a CAGR of 6.53% from 2021 to 2026. In research and therapy, virology has a specific use in gene therapy or vaccinology, which is undoubtedly a key driving factor for the global virology market to grow eventually.

Virology is the branch of the sciences that focuses on the study of viruses.

MARKET DRIVERS:

Due to the high prevalence of diseases such as hepatitis, STDs, AIDS, and flu, the global virology market is forecasted to experience significant growth during the forecast period.

The rise in the incidences of various chronic disorders is also propelling the demand of the market. Initiative steps by government and non-government organizations in creating awareness over the availability of different diagnostic and treatment procedures are accelerating the growth rate of the virology market. The rising number of patients suffering from Flu, Zika virus, STDs, AIDS, and Ebola virus is also leveraging the demand of this market to the extent. 

During the 2016 year, the spread of the Zika virus in the Western Hemispheric region was officially announced by WHO as a warning signal. Found that disease vector Aedes aegypti as a strong thrive in subtropical and tropical climate conditions, which helped the global virology market to see aggressive growth in the past. The global virology market is receiving further accelerated due to the prevention and cure needs; several diseases continue to demand R&D of novel applications.

Extensive virology applications in various therapies such as phage therapy, gene therapysynthetic biology, and the formulation of vaccines are adding fuel to the growth. Moreover, an extension of virology fields, including pediatric virology, computational virology, molecular virology, and other forms. Also, during the forecast period, the awareness of programs across the world and high research prospects are expected to see a spike, which is further predicted to favor the global virology market.

The emergence of the latest technologies in the medical sector and the focus on introducing innovative products are anticipated to create growth opportunities for the virology market. Besides, the rise in investments in pharmaceutical companies by public and private institutes significantly influences the growth rate of the virology market. Escalating expenditure on healthcare services is also one of the factors fuelling the demand of the market. 

As per the WHO (World Health Organisation), approximately 3.5 million people were passed away due to COPD (chronic obstructive pulmonary disease), and nearly 235 million people have asthma. Y-O-Y growth in the population suffering from tuberculosis is the primary factor to drive the demand for the bacteriology testing and virology markets. This growing incidence and prevalence are expected to offer significant growth scope to the global virology market. The rise in healthcare expenditure in developed and developing countries, the increasing investments by private and public bodies, and technological advancements in this field further boost the growth rate of the market. Additionally, reimbursement policies in developing countries and regulating the scenarios in several ways are also spurring the virology market.

MARKET RESTRAINTS:

However, fluctuations in the prices of vaccines and drugs due to the decreasing availability of raw materials are slowly degrading the market demand. The absence of skilled people in laboratories to deal with the latest equipment is also hampering the growth rate of the virology market. The challenging factor for the virology market players is the lack of standardization. Frequent changes in the economic strategies may also negatively impact the growth rate of this market. Stringent rules and regulations by the government to approve the new products regarding people’s safety are also a degrading factor for market growth. 

Impact of COVID-19 on the global virology market:

The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks (COVID-19) were brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. The COVID-19 pandemic has had a significant effect on the global economy at different levels, including the healthcare sector. Coronaviruses are small enveloped positive-stranded RNA viruses. The viral RNA genomes of these viruses are the largest known. Virology is studying viruses and bacteria, which involves identifying, classifying, and characterizing different species. Various methods, such as specific antibody identification, cell culture system, virus nucleic acid detection, antigen detection, and gene sequencing, can be used to diagnose viral infections. Immunoprophylaxis, antiviral chemotherapy, and interferon will also help to control viral infection. The global virology market's businesses are consistently focused on the prevention and cure of multiple diseases. And so, certain disorders need ongoing research and development to obtain high-quality treatment. Virology and bacteriology testing may be used to diagnose diseases of the respiratory system, urinary tract, bloodstream, gastrointestinal and periodontal diseases, sexually transmitted diseases triggered by viruses and bacteria, etc. By considering all these factors, the Virology market has moderate growth during this Covid-19 pandemic.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global virology market has been segmented and sub-segmented based on type, application, end-user, and region.

Virology Market – By Type:

  • Diagnosing Test     
    • DNA Viruses
    • RNA Viruses
    • Prions Diagnostic Test
    • Other Viral Tests
  • Viral Infection Controlling Methods             
    • Immunoprophylaxis
    • Active Prophylaxis (Vaccines)
    • Passive Prophylaxis
  • Antiviral Chemotherapy    
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons             
    • Cytokines

Based on type, the diagnosing test segment holds the largest shares in the global virology market due to the rise in early diagnosis prevalence. An increasing number of viral infections across the world is lavishing the demand of the market.

Virology Market – By Application:

  • Skin and Soft Tissue Infections       
  • Respiratory Tract Infections             
  • GI Tract Infections
  • Urinary Tract Infections     
  • Eye Infections       
  • CNS Infections       
  • Sexually Transmitted Diseases       
  • Perinatal Infections

Based on application, the skin and soft tissue infections category are ruling with dominant shares of the global virology market. Continuous growth in the economy, especially in developed and developing countries, is likely to bolster the growth rate of the market.   

Virology Market – By End User:

  • Hospitals  
  • Clinics        
  • Laboratories           
  • Diagnostic Centres
  • Blood Banks
  • Pharmacies

Based on end-user, the Hospitals and Clinics segments are the largest segments, which account for nearly 50% of the market share.

The hospital's segment is growing at a higher rate for the past few years. The rise in the construction of hospitals with the latest equipment with the government's support is elevating the demand of the market.

Virology Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America is holding the highest shares of the global virology market owing to the quick adoption of advanced technologies. The launch of innovative products in favor of the end-users is also magnifying the demand of the market. In North America, the United States' largest share was accounted for due to technological developments such as portable diagnostics and predicted that the North American region would stay as the top-leading region throughout the forecast period.  

Europe is next to North America in leading prominent shares of the market. Moreover, the European region records the highest compound annual growth rate due to the enhancement of healthcare infrastructure, growth of affordable diagnosis tests for viral diseases, and facilitating diagnostics access.

The Asia Pacific is deemed to have a steady pace in the coming years with the increasing population. Considerable investments in the hospitals and pharmaceutical companies are straight promoting the growth rate of the market in this region. In the current situation, the Japan region has a growing market share in the virology market and estimates the highest compound annual growth rate by 2025. Also, APEJ and Africa are witnessing the most promising growth opportunities over the forecast period. APEJ region compressing China country, and Indian Country are contributing the largest revenue share in virology market.   

KEY MARKET PLAYERS:

A list of key industry leaders playing a crucial role in the global virology market profiled in this report is Boehringer Ingelheim Corporation, Merck, and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

RECENT MARKET HAPPENINGS:

  • The existence of a strong product pipeline, like Merck and Abbvie, with their healthy pipeline products targeting different viruses, is expected to aid the growth of virology therapeutics in the coming future.
  • In April 2020, an announcement was by GSK that they joined forces with Sanofi. This collaboration of the two largest companies helps against COVID-19 by combining their innovative technology to develop a vaccine for COVID-19.
  • In June 2020, a scientific collaboration was made between Clover and GSK's to discover the vaccine for the COVID-19 pandemic. These collaborations result in output as data from research activities within a few months.
  • In 2016, ebola, hepatitis C viruses, and MERS 2 were influenced predominantly in the virology industry. Many collaborations and acquisitions were made between major key players as a solution because of Zika Virus dominance.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Diagnosing Test     

                                                5.1.2.1 DNA Viruses

                                                5.1.2.2 RNA Viruses

                                                5.1.2.3 Prions Diagnostic Test

                                                5.1.2.4 Other Viral Tests

                                5.1.3 Viral Infection Controlling Methods             

                                                5.1.3.1 Immunoprophylaxis

                                                5.1.3.2 Active Prophylaxis (Vaccines)

                                                5.1.3.3 Passive Prophylaxis

                                5.1.4 Antiviral Chemotherapy    

                                                5.1.4.1 Virucidal Agents

                                                5.1.4.2 Antiviral Agents

                                                5.1.4.3 Immunomodulators

                                5.1.5 Interferons             

                                                5.1.5.1 Cytokines

                                5.1.6 Y-o-Y Growth Analysis, By Type     

                                5.1.7 Market Attractiveness Analysis, By Type   

                                5.1.8 Market Share Analysis, By Type     

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Skin and Soft Tissue Infections       

                                5.2.3 Respiratory Tract Infections             

                                5.2.4 GI Tract Infections

                                5.2.5 Urinary Tract Infections     

                                5.2.6  Eye Infections       

                                5.2.7 CNS Infections       

                                5.2.8 Sexually Transmitted Diseases       

                                5.2.9 Perinatal Infections             

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11  Market Attractiveness Analysis, By Application   

                                5.2.12  Market Share Analysis, By Application     

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Laboratories           

                                5.3.5 Diagnostic Centres               

                                5.3.6 Blood Banks            

                                5.3.7 Pharmacies             

                                5.3.8 Y-o-Y Growth Analysis, By End User             

                                5.3.9  Market Attractiveness Analysis, By End User          

                                5.3.10  Market Share Analysis, By End User         

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Johnson & Johnson                 

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories               

                8.3 GlaxoSmithKline plc                

                8.4 Boehringer Ingelheim Corporation                   

                8.5 Merck and Co. Inc.                  

                8.6 Novartis International AG                    

                8.7 Siemens                       

                8.8 AstraZeneca AB                        

                8.9 Roche                           

                8.10 Abivax                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Virology Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Virology Market, By Type, From 2021 to 2026 (USD Million)
  3. Global Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Interferons Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Virology Market, By Application, From 2021 to 2026 (USD Million)
  8. Global Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  9. Global GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  12. Global CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Virology Market, By End User, From 2021 to 2026 (USD Million)
  16. Global Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  17. Global Clinics Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  20. Global Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  21. Global Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Virology Market, By Type, From 2021 to 2026 (USD Million)
  23. North America Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Interferons Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Virology Market, By Application, From 2021 to 2026 (USD Million)
  28. North America Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  29. North America GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  32. North America CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Virology Market, By End User, From 2021 to 2026 (USD Million)
  36. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Clinics Market, By Region, From 2021 to 2026 (USD Million)
  38. North America Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  39. North America Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  40. North America Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  41. North America Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  42. United States Virology Market, By Type, From 2021 to 2026 (USD Million)
  43. United States Virology Market, By Application, From 2021 to 2026 (USD Million)
  44. United States Virology Market, By End User, From 2021 to 2026 (USD Million)
  45. Canada Virology Market, By Type, From 2021 to 2026 (USD Million)
  46. Canada Virology Market, By Application, From 2021 to 2026 (USD Million)
  47. Canada Virology Market, By End User, From 2021 to 2026 (USD Million)
  48. Europe Virology Market, By Type, From 2021 to 2026 (USD Million)
  49. Europe Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  50. Europe Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  51. Europe Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  52. Europe Interferons Market, By Region, From 2021 to 2026 (USD Million)
  53. Europe Virology Market, By Application, From 2021 to 2026 (USD Million)
  54. Europe Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  55. Europe GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  58. Europe CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  59. Europe Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  60. Europe Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  61. Europe Virology Market, By End User, From 2021 to 2026 (USD Million)
  62. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe Clinics Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  66. Europe Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  67. Europe Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  68. U.K. Virology Market, By Type, From 2021 to 2026 (USD Million)
  69. U.K. Virology Market, By Application, From 2021 to 2026 (USD Million)
  70. U.K. Virology Market, By End User, From 2021 to 2026 (USD Million)
  71. Germany Virology Market, By Type, From 2021 to 2026 (USD Million)
  72. Germany Virology Market, By Application, From 2021 to 2026 (USD Million)
  73. Germany Virology Market, By End User, From 2021 to 2026 (USD Million)
  74. France Virology Market, By Type, From 2021 to 2026 (USD Million)
  75. France Virology Market, By Application, From 2021 to 2026 (USD Million)
  76. France Virology Market, By End User, From 2021 to 2026 (USD Million)
  77. Italy Virology Market, By Type, From 2021 to 2026 (USD Million)
  78. Italy Virology Market, By Application, From 2021 to 2026 (USD Million)
  79. Italy Virology Market, By End User, From 2021 to 2026 (USD Million)
  80. Spain Virology Market, By Type, From 2021 to 2026 (USD Million)
  81. Spain Virology Market, By Application, From 2021 to 2026 (USD Million)
  82. Spain Virology Market, By End User, From 2021 to 2026 (USD Million)
  83. Asia Pacific Virology Market, By Type, From 2021 to 2026 (USD Million)
  84. Asia Pacific Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  85. Asia Pacific Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  86. Asia Pacific Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  87. Asia Pacific Interferons Market, By Region, From 2021 to 2026 (USD Million)
  88. Asia Pacific Virology Market, By Application, From 2021 to 2026 (USD Million)
  89. Asia Pacific Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  90. Asia Pacific GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  91. Asia Pacific Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  92. Asia Pacific Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  93. Asia Pacific CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  94. Asia Pacific Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  95. Asia Pacific Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  96. Asia Pacific Virology Market, By End User, From 2021 to 2026 (USD Million)
  97. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  98. Asia Pacific Clinics Market, By Region, From 2021 to 2026 (USD Million)
  99. Asia Pacific Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  100. Asia Pacific Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  101. Asia Pacific Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  102. Asia Pacific Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  103. Japan Virology Market, By Type, From 2021 to 2026 (USD Million)
  104. Japan Virology Market, By Application, From 2021 to 2026 (USD Million)
  105. Japan Virology Market, By End User, From 2021 to 2026 (USD Million)
  106. China Virology Market, By Type, From 2021 to 2026 (USD Million)
  107. China Virology Market, By Application, From 2021 to 2026 (USD Million)
  108. China Virology Market, By End User, From 2021 to 2026 (USD Million)
  109. India Virology Market, By Type, From 2021 to 2026 (USD Million)
  110. India Virology Market, By Application, From 2021 to 2026 (USD Million)
  111. India Virology Market, By End User, From 2021 to 2026 (USD Million)
  112. Australia Virology Market, By Type, From 2021 to 2026 (USD Million)
  113. Australia Virology Market, By Application, From 2021 to 2026 (USD Million)
  114. Australia Virology Market, By End User, From 2021 to 2026 (USD Million)
  115. South Korea Virology Market, By Type, From 2021 to 2026 (USD Million)
  116. South Korea Virology Market, By Application, From 2021 to 2026 (USD Million)
  117. South Korea Virology Market, By End User, From 2021 to 2026 (USD Million)
  118. Latin America Virology Market, By Type, From 2021 to 2026 (USD Million)
  119. Latin America Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  120. Latin America Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  121. Latin America Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  122. Latin America Interferons Market, By Region, From 2021 to 2026 (USD Million)
  123. Latin America Virology Market, By Application, From 2021 to 2026 (USD Million)
  124. Latin America Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  125. Latin America GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  126. Latin America Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  127. Latin America Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  128. Latin America CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  129. Latin America Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  130. Latin America Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  131. Latin America Virology Market, By End User, From 2021 to 2026 (USD Million)
  132. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  133. Latin America Clinics Market, By Region, From 2021 to 2026 (USD Million)
  134. Latin America Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  135. Latin America Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  136. Latin America Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  137. Latin America Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  138. Brazil Virology Market, By Type, From 2021 to 2026 (USD Million)
  139. Brazil Virology Market, By Application, From 2021 to 2026 (USD Million)
  140. Brazil Virology Market, By End User, From 2021 to 2026 (USD Million)
  141. Argentina Virology Market, By Type, From 2021 to 2026 (USD Million)
  142. Argentina Virology Market, By Application, From 2021 to 2026 (USD Million)
  143. Argentina Virology Market, By End User, From 2021 to 2026 (USD Million)
  144. Mexico Virology Market, By Type, From 2021 to 2026 (USD Million)
  145. Mexico Virology Market, By Application, From 2021 to 2026 (USD Million)
  146. Mexico Virology Market, By End User, From 2021 to 2026 (USD Million)
  147. Rest of Latin America Virology Market, By Type, From 2021 to 2026 (USD Million)
  148. Rest of Latin America Virology Market, By Application, From 2021 to 2026 (USD Million)
  149. Rest of Latin America Virology Market, By End User, From 2021 to 2026 (USD Million)
  150. Middle East and Africa Virology Market, By Type, From 2021 to 2026 (USD Million)
  151. Middle East and Africa Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  152. Middle East and Africa Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  153. Middle East and Africa Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  154. Middle East and Africa Interferons Market, By Region, From 2021 to 2026 (USD Million)
  155. Middle East and Africa Virology Market, By Application, From 2021 to 2026 (USD Million)
  156. Middle East and Africa Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  157. Middle East and Africa GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  158. Middle East and Africa Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  159. Middle East and Africa Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  160. Middle East and Africa CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  161. Middle East and Africa Sexually Transmitted Diseases Market, By Region, From 2021 to 2026 (USD Million)
  162. Middle East and Africa Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  163. Middle East and Africa Virology Market, By End User, From 2021 to 2026 (USD Million)
  164. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  165. Middle East and Africa Clinics Market, By Region, From 2021 to 2026 (USD Million)
  166. Middle East and Africa Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  167. Middle East and Africa Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  168. Middle East and Africa Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  169. Middle East and Africa Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  170. Middle East Virology Market, By Type, From 2021 to 2026 (USD Million)
  171. Middle East Virology Market, By Application, From 2021 to 2026 (USD Million)
  172. Middle East Virology Market, By End User, From 2021 to 2026 (USD Million)
  173. Africa Virology Market, By Type, From 2021 to 2026 (USD Million)
  174. Africa Virology Market, By Application, From 2021 to 2026 (USD Million)
  175. Africa Virology Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample